Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 3:1
Drug Approvals
1
FDA:1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)β’ Click on a phase to view related trials
Phase 3
1 (100.0%)[18F]PI-2620 Phase 3 Histopathological Study
- First Posted Date
- 2022-12-08
- Last Posted Date
- 2025-06-22
- Lead Sponsor
- Life Molecular Imaging Ltd
- Target Recruit Count
- 200
- Registration Number
- NCT05641688
- Locations
- πΊπΈ
Barrow Neurological Institute, Phoenix, Arizona, United States
πΊπΈBanner Sun Health Research Institute, Sun City, Arizona, United States
πΊπΈUC Los Angeles, Los Angeles, California, United States
News
No news found